Related Experiment Videos
Keratinocytes in inflammatory skin diseases
Cristina Albanesi1, Claudia Scarponi, Maria L Giustizieri
1Laboratory of Immunology, Istituto Dermopatico dell'Immacolata, IRCCS, Rome, Italy. c.albanesi@idi.it
Current Drug Targets. Inflammation and Allergy
|August 17, 2005
Summary
Skin keratinocytes are active immune participants, not passive targets. Their signaling molecules influence immune cells, and their dysregulation contributes to inflammatory skin diseases like psoriasis and atopic dermatitis.
Area of Science:
- Immunodermatology
- Cutaneous Immunology
- Skin Biology
Background:
- Historically, keratinocytes were viewed as passive targets in skin immunity.
- Emerging evidence highlights keratinocytes' active role in immune responses.
- Understanding keratinocyte function is crucial for inflammatory skin disease research.
Purpose of the Study:
- To elucidate the active role of keratinocytes in cutaneous immunity.
- To explore how keratinocytes modulate innate and adaptive immune cells.
- To connect keratinocyte-derived mediators to the pathogenesis of skin diseases.
Main Methods:
- Review of existing immunological and dermatological studies.
- Analysis of cytokine, chemokine, and accessory molecule expression in keratinocytes.
- Examination of signaling pathways involved in keratinocyte-immune cell interactions.
Main Results:
- Activated keratinocytes express numerous signaling molecules (cytokines, chemokines).
- These molecules mediate both stimulatory and inhibitory signals to immune cells.
- Keratinocyte-derived mediators play a significant role in immune regulation.
Conclusions:
- Keratinocytes are key active players in skin immune responses.
- Aberrant keratinocyte signaling contributes to chronic inflammatory skin conditions.
- Targeting keratinocyte pathways may offer therapeutic strategies for diseases like psoriasis and atopic dermatitis.